Commissioners question Royal Free's planned £30m overperformance

The acute trust’s most recent finance report said the clinical commissioning groups had “raised concerns about their ability to fund a forecast outturn  of £30m overperformance”.

The trust had a deficit of £14.2m at the end of the first quarter, which was in line with its plan. The multi-site provider is predicting a £15.5m surplus for the financial year, subject to its achieving the targets it has been set to receive £18.3m in sustainability and transformation fund cash.

The finance director’s report to the board said there had been “slow progress in identifying cost reduction programmes against the £46.3m savings target”. The report said there were “firmed up” plans totalling £7.4m “and ideas of £21.4m”.